174 related articles for article (PubMed ID: 1735696)
1. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
[TBL] [Abstract][Full Text] [Related]
2. KIH-802, an acetohydroxamic acid derivative of 2-nitroimidazole, as a new potent hypoxic cell radiosensitizer: radiosensitizing activity, acute toxicity, and pharmacokinetics.
Sasai K; Shibamoto Y; Takahashi M; Zhou L; Hori H; Nagasawa H; Shibata T; Inayama S; Abe M
Cancer Chemother Pharmacol; 1990; 26(2):112-6. PubMed ID: 2140730
[TBL] [Abstract][Full Text] [Related]
3. KIH-802: 2-nitroimidazole-1-acetohydroxamate as a hypoxic cell radiosensitizer.
Hori H; Murayama C; Mori T; Shibamoto Y; Abe M; Onoyama Y; Inayama S
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1029-32. PubMed ID: 2703381
[TBL] [Abstract][Full Text] [Related]
4. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
[TBL] [Abstract][Full Text] [Related]
5. In vivo radiosensitizing effect of nitroimidazole derivative KIN-804.
Tada T; Nakajima T; Onoyama Y; Murayama C; Mori T; Nagasawa H; Hori H; Inayama S
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):601-5. PubMed ID: 8005823
[TBL] [Abstract][Full Text] [Related]
6. [Radiosensitizing effects of nitroimidazole derivative, KIN-804].
Tada T
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jan; 55(1):70-5. PubMed ID: 7899069
[TBL] [Abstract][Full Text] [Related]
7. [Development of new hypoxic cell radiosensitizer in Japan].
Mori T; Murayama C
Gan No Rinsho; 1988 Oct; 34(13):1869-74. PubMed ID: 2974089
[TBL] [Abstract][Full Text] [Related]
8. A new, potent 2-nitroimidazole nucleoside hypoxic cell radiosensitizer, RP170.
Sasai K; Shibamoto Y; Takahashi M; Abe M; Wang J; Zhou L; Nishimoto S; Kagiya T
Jpn J Cancer Res; 1989 Nov; 80(11):1113-8. PubMed ID: 2532634
[TBL] [Abstract][Full Text] [Related]
9. KIN-804 vs. KU-2285 as a radiosensitizer for clinical use.
Oya N; Shibamoto Y; Shibata T; Murata R; Iwai H; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):595-600. PubMed ID: 8005822
[TBL] [Abstract][Full Text] [Related]
10. Fluorine modification of nitroazole radiosensitizers for the enhancement of sensitizing activity with lowering toxicity: a pharmacokinetic characterization.
Kagiya VT; Nishimoto S; Ito T; Wang J; Abe M; Sasai K
Int J Radiat Oncol Biol Phys; 1992; 22(3):601-5. PubMed ID: 1735699
[TBL] [Abstract][Full Text] [Related]
11. [Present status of radiation sensitizers--hypoxic cell radiosensitizer].
Murayama C; Mori T
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2135-41. PubMed ID: 2660744
[TBL] [Abstract][Full Text] [Related]
12. [Radiosensitizer: hypoxic cell radiosensitizer].
Mori T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1399-404. PubMed ID: 2525001
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of fluorinated nitroazoles as hypoxic cell radiosensitizers.
Shibamoto Y; Nishimoto S; Shimokawa K; Hisanaga Y; Zhou L; Wang J; Sasai K; Takahashi M; Abe M; Kagiya T
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1045-8. PubMed ID: 2703384
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
Brown DM; Yu NY; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).
Murayama C; Suzuki A; Suzuki T; Miyata Y; Sakaguchi M; Tanabe Y; Tanaka N; Mori T
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):575-81. PubMed ID: 2528527
[TBL] [Abstract][Full Text] [Related]
16. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
Zhou L; Nishimoto S
Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing activity and pharmacokinetics of multiple dose administered KU-2285 in peripheral nerve tissue in mice.
Iwai H; Matsuno E; Sasai K; Shibamoto Y; Abe M
Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):591-4. PubMed ID: 8005821
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a new 2-nitroimidazole nucleoside analogue, RK-28 as a radiosensitizer for clinical use.
Shibamoto Y; Sasai K; Sakaguchi M; Tamulevicius P; Kitakabu Y; Streffer C; Abe M
Int J Radiat Biol; 1991 Jan; 59(1):105-15. PubMed ID: 1671058
[TBL] [Abstract][Full Text] [Related]
19. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity.
Oya N; Shibamoto Y; Sasai K; Shibata T; Murata R; Takagi T; Iwai H; Suzuki T; Abe M
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):119-27. PubMed ID: 7642409
[TBL] [Abstract][Full Text] [Related]
20. Newly synthesized hypoxia-mediated drugs as radiosensitizers and cytotoxic agents.
Astor M; Hall EJ; Biaglow JE; Parham JC
Int J Radiat Oncol Biol Phys; 1982 Jan; 8(1):75-83. PubMed ID: 7061257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
